Arumugam Mohanapriya

Dr. Arumugam Mohanapriya


Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 April 2025 in Journal of Translational Medicine
Verified
Journal Article
Open access
PDF file
HSHarshini Senthilkumar
Harshini Senthilkumar
AMArumugam Mohanapriya
Arumugam Mohanapriya
Polycystic ovary syndrome (PCOS) is an endocrine disorder that affects reproductive-aged women worldwide, causing hormonal imbalances and ovarian dysfunction. PCOS affects metabolic health and increases the risk of obesity, insulin resistance, and cardiovascular disease, in addition to infertility. This review delves deeper into the connections of gut microbiota with PCOS pathophysiology, particularly into its impact on hormone metabolism, obesity, inflammation, and insulin resistance by way of short-chain fatty acids, lipopolysaccharides, and gut-brain axis. Studies also show that changes in the metabolic processes and immune responses are seen in changes in the gut microbiota in PCOS subjects, such as changes in the Bacteroidetes and Firmicutes groups. Some bacteria, like Escherichia and Shigella, have been associated with dysbiosis in patients with PCOS, leading to systemic inflammation and changed hormone levels, which further worsen the clinical symptoms. Therapeutic interventions targeting the gut microbiota comprise probiotics, prebiotics, and fecal microbiota transplantation; these have potential to alleviate the symptoms of PCOS. Other precision microbiome-based therapies include postbiotics, and CRISPR-Cas9 genome editing, which are relatively new avenues toward precision treatment. This complex interlink of gut microbiota and PCOS pathophysiology will open the avenues for possible treatments for hormonal imbalances and metabolic problems that characterize these complex disorders. The review here focuses on the requirement of further studies to be able to elucidate the specific pathways relating gut microbiota dysregulation to PCOS and, thus, improve microbiome-based therapies for better clinical outcomes in affected individuals.

16 March 2017 in Medicinal Chemistry Research
Verified
Journal Article
Closed access
PDF file
TST. V. Sravanthi
T. V. Sravanthi
SLS. Sajitha Lulu
S. Sajitha Lulu
VSVino Sundararajan
Vino Sundararajan
MJM. A. Jayasri
M. A. Jayasri
AMArumugam Mohanapriya
Arumugam Mohanapriya
SMS. L. Manju
S. L. Manju

10 March 2015 in Natural Product Research
Verified
Journal Article
Closed access
SSSajitha Lulu S
Sajitha Lulu S
ATA Thabitha
A Thabitha
VSVino Sundararajan
Vino Sundararajan
AMArumugam Mohanapriya
Arumugam Mohanapriya
MRMadhusmita Rout
Madhusmita Rout
Nonstructural proteins of hepatitis C virus had drawn much attention for the scientific fraternity in drug discovery due to its important role in the disease. 3D structure of the protein was predicted using molecular modelling protocol. Docking studies of 10 medicinal plant compounds and three drugs available in the market (control) with NS2 protease were employed by using rigid docking approach of AutoDock 4.2. Among the molecules tested for docking study, naringenin and quercetin revealed minimum binding energy of − 7.97 and − 7.95 kcal/mol with NS2 protease. All the ligands were docked deeply within the binding pocket region of the protein. The docking study results showed that these compounds are potential inhibitors of the target; and also all these docked compounds have good inhibition constant, vdW+Hbond+desolv energy with best RMSD value.

11 March 2016 in PLOS ONE
Verified
Journal Article
Open access
PDF file
SSSudharsana Sundarrajan
Sudharsana Sundarrajan
AMArumugam Mohanapriya
Arumugam Mohanapriya
Increasing epidemiological studies in patients with psoriasis report the frequent occurrence of one or more associated disorders. Psoriasis is associated with multiple comorbidities including autoimmune disease, neurological disorders, cardiometabolic diseases and inflammatory-bowel disease. An integrated system biology approach is utilized to decipher the molecular alliance of psoriasis with its comorbidities. An unbiased integrative network medicine methodology is adopted for the investigation of diseasome, biological process and pathways of five most common psoriasis associated comorbidities. A significant overlap was observed between genes acting in similar direction in psoriasis and its comorbidities proving the mandatory occurrence of either one of its comorbidities. The biological processes involved in inflammatory response and cell signaling formed a common basis between psoriasis and its associated comorbidities. The pathway analysis revealed the presence of few common pathways such as angiogenesis and few uncommon pathways which includes CCKR signaling map and gonadotrophin-realising hormone receptor pathway overlapping in all the comorbidities. The work shed light on few common genes and pathways that were previously overlooked. These fruitful targets may serve as a starting point for diagnosis and/or treatment of psoriasis comorbidities. The current research provides an evidence for the existence of shared component hypothesis between psoriasis and its comorbidities.

9 September 2023 in Ageing Research Reviews
Verified
Journal Article
Closed access
PSPriyanka Saha
Priyanka Saha
SPSubhrajita Panda
Subhrajita Panda
AHAayusha Holkar
Aayusha Holkar
RVRahul Vashishth
Rahul Vashishth
SRSandeep Singh Rana
Sandeep Singh Rana
FAFaraz Ahmad
Faraz Ahmad

5 February 2016 in Journal of Fish Diseases
Verified
Journal Article
Closed access
PDF file
SSS Sudharsana
S Sudharsana
CRC B Rajashekar Reddy
C B Rajashekar Reddy
SDS Dinesh
S Dinesh
DRDr.S. Rajasekhar
Dr.S. Rajasekhar
AMArumugam Mohanapriya
Arumugam Mohanapriya
RSR Sudhakaran
R Sudhakaran